ARTRX Mutual Fund

ARTRX Mutual Fund

NAV$35.99
See how much of ARTRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.19%
Dividend Yield (Current)
3.44%
Holdings
57
Inception Date
Sep 22, 2008
Fund Family
Artisan Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.09%
1 Year+4.91%
3 Year+11.89%
5 Year+2.75%
10 Year+10.81%

Asset Allocation

Stocks: 97.13%
Cash: 2.87%
See how much of ARTRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
AMZNAmazon.Com Inc6.05%
BAES:LNBae Systems Plc4.66%
ARGX:ASArgenx Se Sponsored Adr (1 Ads : 1 Ordinary)3.97%
INSMInsmed Inc3.89%
AVGOBroadcom Inc3.80%
Top 10 Concentration: 40.67%Report Date: Mar 31, 2026
Download all 57 holdings for ARTRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.44%
Frequency
Annually
Latest Distribution
$3.98
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ARTRX Mutual Fund Overview

ARTRX Mutual Fund (Artisan Global Opportunities Fund Inv Shs) is managed by Artisan Partners. ARTRX expense ratio is 1.19%, holding 57 positions across sectors including Health Care, Information Technology, Financials. Inception date: 2008-09-22.

ARTRX performance shows a YTD return of 3.09%. The 1-year return is 4.91% and the 5-year return is 2.75%. ARTRX dividend yield stands at 3.44%, paid annually.

ARTRX top holdings include Amazon.Com Inc (6.0%), Bae Systems Plc (4.7%), Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (4.0%), Insmed Inc (3.9%), Broadcom Inc (3.8%). Go to all ARTRX holdings, ARTRX sectors, or ARTRX dividends.

ARTRX can be compared against other funds. Use ARTRX overlap to find shared positions, or ARTRX vs another fund for a side-by-side view. ARTRX alternatives are available via the screener, along with tax-loss harvesting opportunities.